Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 NET 1 Genitourinary 1 Endocrine 1

Conditions

Neuroendocrine Tumors 26 Sarcoma 4 Carcinoma, Neuroendocrine 4 Prostatic Neoplasms 3 Pheochromocytoma 3 Paraganglioma 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma 3 Breast Neoplasms 3 Adenoma, Islet Cell 3 Thyroid Neoplasms 2 Stomach Neoplasms 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Meningioma 2 Melanoma 2 Liver Neoplasms 2 Head and Neck Neoplasms 2 Gastrointestinal Neoplasms 2 Gastro-enteropancreatic neuroendocrine tumor 2 Digestive System Neoplasms 2 Colonic Neoplasms 2 Colonic Diseases 2 Carcinoma, Renal Cell 2 Carcinoid Tumor 2 Adenocarcinoma 2

Interventions

lutetium Lu 177 dotatate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Disease Progression × NET × 30 days × Clear all

NCT04954820 2026-06-04

ReLUTH

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 2 Recruiting

Neuroendocrine Tumors, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡